PRA Health Sciences (PRAH) Tops Q3 EPS by 7c; Lifts FY15 EPS Outlook
Get Alerts PRAH Hot Sheet
Join SI Premium – FREE
PRA Health Sciences (NASDAQ: PRAH) reported Q3 EPS of $0.52, $0.07 better than the analyst estimate of $0.45. Revenue for the quarter came in at $345.1 million versus the consensus estimate of $346.05 million.
PRA Health Sciences sees FY2015 EPS of $1.89-$1.92, versus prior guidance of $1.75-$1.85 and the consensus of $1.81.
For earnings history and earnings-related data on PRA Health Sciences (PRAH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
- Impinj (PI) Tops Q1 EPS by 11c, provides guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!